Favorable first-pass recanalization rates with NeVa™ thrombectomy device in acute stroke patients: Initial clinical experience

Abstract

Background

The NeVa™ thrombectomy device (Vesalio LLC, Nashville, USA) has been reported to succeed in large vessel occlusion thrombectomy in animal, in-vitro, and clinical studies. Designed with Drop Zone technology, a closed distal tip, and strong expansive radial force, the device demonstrated particular efficiency in resistant “white” thrombi in preclinical research. Our goal is to determine the safety and performance of this novel stent retriever on first-pass rates and overall recanalization.

Methods

The Interventional Neurology Database is a prospectively maintained database of anterior and posterior circulation stroke thrombectomy cases. We retrospectively analyzed cases where the NeVa™ thrombectomy device was used as the first-line treatment strategy. Data collection occurred between January 2019 and January 2020. First-pass recanalization, final recanalization, 90-day functional outcome, complication, and bleeding rates are reported.

Results

One hundred eighteen patients were treated with the NeVa™ thrombectomy device. The mean patient age was 69 ± 14 years, the median baseline National Institutes of Health Stroke Scale was 14, and the median initial Alberta Stroke Program Early Computed Tomography score was 8. The median time from groin puncture to successful recanalization was 29 min (interquartile range (IQR): 20–40). First-pass recanalization rates were 56.8% (modified treatment in cerebral infarction (mTICI) 2b/3) and 44.9% (mTICI 2c/3). Final successful recanalization rate was 95.8% (thrombolysis in cerebral infarction 2b/3). Favorable functional outcome (modified Rankin Scale 0–2) was 53% in the “first-pass” subgroup and 42.4% in the total patient population. The median number of passes to achieve the final recanalization score was 1 (IQR 1–2). The rate of embolization into new territory was 1.7%. Four patients (3.3%) had symptomatic hemorrhage.

Conclusions

In our experience, the NeVa™ device demonstrated high first-pass and overall recanalization rates along with a good safety profile.

Keywords

Acute stroke excellent outcome first-pass recanalization NeVa™ device thrombectomy device

Get full access to this article

View all access options for this article.

References

Tung

McTaggart

Baird

, et al. Rethinking thrombolysis in cerebral infarction 2b: which thrombolysis in cerebral infarction scales best define near complete recanalization in the modern thrombectomy era? Stroke 2017; 48: 2488–2493.

Albers

Marks

Kemp

, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018; 378: 708–718.

Nogueira

Jadhav

Haussen

, et al. Thrombectomy 6 to 24 hours after stroke with a mis-match between deficit and infarct. N Engl J Med 2018; 378: 11–21.

Touma

Filion

Sterling

, et al. Stent retrievers for the treatment of acute ischemic stroke: a systematic review and meta-analysis of randomized clinical trials. JAMA Neurol 2016; 73: 275–281.

Saber

Rajah

Kherallah

, et al. Comparison of the efficacy and safety of thrombectomy devices in acute stroke: a network meta-analysis of randomized trials. J Neurointerv Surg 2018; 10: 729–734.

Kleine

Wunderlich

Zimmer

, et al. Time to redefine success? TICI 3 versus TICI 2b recanalization in middle cerebral artery occlusion treated with thrombectomy. J Neurointerv Surg 2017; 9: 117–121.

Goyal

Fargen

Turk

, et al. 2b-2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J Neurointerv Surg 2014; 6: 83–86.

Saver

Goyal

Van der Lugt

, et al. HERMES collaborators. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016; 316: 1279–1288.

Zaidat

Bozorgchami

Ribó

, et al. Primary results of the multicenter ARISE II study (Analysis of revascularization in ischemic stroke with EmboTrap). Stroke 2018; 49: 1107–1115.

10.

Machi

Jourdan

Ambard

, et al. Experimental evaluation of stent retrievers mechanical properties and effectiveness. J Neurointerv Surg 2017; 9: 257–263.

11.

Yuki

Kan

Vinters

, et al. The impact of thromboemboli histology on the performance of a mechanical thrombectomy device. Am J Neuroradiol 2012; 33: 643–648.

12.

Ulm

Khachatryan

Grigorian

, et al. Preclinical evaluation of the NeVa™ stent retriever: safety and efficacy in the swine thrombectomy model. Intervent Neurol 2018; 7: 205–217.

13.

Machi

Ulm

Bernava

, et al. Experimental evaluation of the NeVa™ thrombectomy device a novel stent retriever conceived to improve efficacy of organized clot removal. J Neuroradiol 2019; 46: 163–167.

14.

Hacke

Kaste

Bluhmki

, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1795–1806.

15.

Turk

Frei

Fiorella

, et al. ADAPT FAST study: a direct aspiration first pass technique for acute stroke thrombectomy. J Neurointerv Surg 2018; 10: 4–7.

16.

Gurkas

Akpinar

Aytac

ADVANCE: an effective and feasible technique in acute stroke treatment.

Interv Neuroradiol 2017; 23: 166–172.

17.

Pereira

Gralla

Davalos

, et al. Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke. Stroke 2013; 44: 2802–2807.

18.

San Roman

Obach

Blasco

, et al. Single center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke. Stroke 2012; 43: 1657–1659.

19.

Kurre

Aguilar-Perez

Schmid

, et al. Clinical experience with pREset stent retriever for the treatment of acute ischemic stroke: a review of 271 consecutive cases. Neuroradiology 2014; 56: 397–403.

20.

Kahles

Garcia-Esperon

Zeller

, et al. Mechanical thrombectomy using the new ERIC retrieval device is feasible, efficient and safe in acute ischemic stroke: a Swiss stroke center experience. Am J Neuroradiol 2016; 37: 114–119.

21.

Kabbasch

Mpotsaris

Liebig

, et al. First-in-man procedural experience with the novel EmboTrap® revascularization device for the treatment of ischemic stroke: a European multicenter series. Clin Neuroradiol 2016; 26: 221–228.

22.

Mordasini

Frabetti

Gralla

, et al. In vivo evaluation of the first dedicated combined flow-restoration and mechanical thrombectomy device in a swine model of acute vessel occlusion. Am J Neuroradiol 2011; 32: 294–300.

23.

Wenger

Nagle

Wagner

, et al. Improvement of stent retriever design and efficacy of mechanical thrombectomy in a flow model. Cardiovasc Intervent Radiol 2013; 36: 192–197.

24.

Haussen

Rebello

Nogueira

RG.

Optimizating clot retrieval in acute stroke: the push and fluff technique for closed cell stentrievers.

Stroke 2015; 46: 2838–2842.

25.

Ribo

Requena

Macho

, et al. Mechanical thrombectomy with a novel stent retriever with multifunctional zones: initial clinical experience with the NeVa™ thrombectomy device. J Neuroradiol 2020; 47: 301–305.

26.

Goyal

Menon

van Zwam

, et al.; HERMES Collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387: 1723–1731.

27.

Arai

Ishii

Chihara

, et al. Histological examination of vascular damage caused by stent retriever thrombectomy devices. J Neurointerv Surg 2016; 8: 992–995.

28.

Flottmann

Leischner

Broocks

, et al. Recanalization rate per retrieval attempt in mechanical thrombectomy for acute ischemic stroke. Stroke 2018; 49: 2523–2525.

29.

García-Tornel

Requena

Rubiera

, et al. When to stop detrimental effect of device passes in acute ischemic stroke secondary to large vessel occlusion. Stroke 2019; 50: 1781–1788.

30.

Bourcier

Saleme

Labreuche

, et al.; ASTER Trial Investigators. More than three passes of stent retriever is an independent predictor of parenchymal hematoma in acute ischemic stroke. J Neurointerv Surg 2019; 11: 625–629.

31.

Hesse

Behme

Kemmling

, et al. Comparing different thrombectomy techniques in five large-volume centers: a ‘real world’ observational study. J Neurointerv Surg 2018; 10: 525–529.

32.

Jindal

Carvalho

HDP

Wessell

, et al. Beyond the first pass: revascularization remains critical in stroke thrombectomy. J NeuroInterv Surg 2019; 11: 1095–1099.

33.

Jovin

Chamorro

Cobo

, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296–2306.

34.

Lavine

Cockroft

Hoh

, et al. Training guidelines for endovascular ischemic stroke intervention: an international multi-society consensus document. J Neurointerv Surg 2016; 8: 989–991.

35.

Lapergue

Blanc

Gory

, et al. Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion. The ASTER Randomized Clinical Trial. JAMA 2017; 318: 443–452.

36.

Turk

Siddiqui

Fifi

, et al. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet 2019; 393: 998–1008.

37.

Sakai N, Imamura H, Adachi H, et al. First-in-man experience of the Versi Retriever in acute ischemic stroke. J NeuroIntervent Surg 2018; 9: 1--4.

38.

Ernst E, Papanagiotoua P, Politia M, et al. Safety and effectiveness of CATCH+ as a first-line device for revascularization in the treatment of acute ischemic stroke. J Neuroradiol 2019; 17: 30442--30447.

39.

Zaidat OO, Castonguay AC, Linfante I, et al. First Pass Effect A New Measure for Stroke Thrombectomy Devices. Stroke 2018; 9: 60--666.

40.

García-Tornel A, Rubiera M, Requena M, et al. Sudden Recanalization, A Game-Changing Factor in Endovascular Treatment of Large Vessel Occlusion Strokes. Stroke 2020; 1: 313--1316.